Thus, it can be concluded that the worst effect on insulin resistance and insulin sensitivity in type 2 diabetic patients with end-stage renal disease and kidney failure may be secondary to the strongest effects of inflammation. This evidence concerns the gene INS and stage 5 chronic kidney disease.